Company Filing History:
Years Active: 2019-2025
Title: Innovations of Inventor Xinbin Gu
Introduction
Xinbin Gu is a notable inventor based in Washington, DC, who has made significant contributions to the field of medical research. He holds 2 patents that focus on innovative methods for treating serious health conditions, particularly in the areas of cancer and diabetes.
Latest Patents
One of his latest patents is titled "Methods for treating triple negative breast cancer using salvianolic acid B." This patent provides methods related to treating triple-negative breast cancer (TNBC) in mammals by administering salvianolic acid B or its salts to promote ceramide-mediated apoptosis. The invention highlights how the ceramide-mediated apoptosis of TNBC cells can be achieved by decreasing the levels of glucosylceramide synthase and GM3 synthase through the effective use of salvianolic acid B. Additionally, this compound is proposed as a medicament for treating TNBC.
Another significant patent by Xinbin Gu is "Salivary biomarkers for monitoring of type 2 diabetes treatment." This disclosure identifies salivary biomarkers that can be used for the diagnosis and monitoring of type 2 diabetes in subjects. The methods described allow for noninvasive diagnosis and monitoring, particularly focusing on the expression of salivary biomarkers such as MUC-1, MUC-2, MUC-4, and MUC-5B, which are highly associated with A1C levels in African American patients with type 2 diabetes.
Career Highlights
Xinbin Gu is affiliated with Howard University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health, particularly in the treatment of chronic diseases.
Collaborations
One of his notable coworkers is Grace Robinson, with whom he collaborates on various research projects aimed at improving health outcomes through innovative solutions.
Conclusion
Xinbin Gu's contributions to medical research through his patents demonstrate his commitment to addressing critical health issues. His innovative approaches in treating triple-negative breast cancer and monitoring type 2 diabetes highlight the importance of research in developing effective medical treatments.